Csokay B - Search Results

1

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D. Neuhausen SL, et al. Among authors: csokay b. Am J Hum Genet. 1998 Jun;62(6):1381-8. doi: 10.1086/301885. Am J Hum Genet. 1998. PMID: 9585613 Free PMC article.

2

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BA, Olah E. Ramus SJ, et al. Among authors: csokay b. Am J Hum Genet. 1997 May;60(5):1242-6. Am J Hum Genet. 1997. PMID: 9150174 Free PMC article. No abstract available.

3

High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.

Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E. Csokay B, et al. Cancer Res. 1999 Mar 1;59(5):995-8. Cancer Res. 1999. PMID: 10070953

4

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E. Van Der Looij M, et al. Among authors: csokay b. Int J Cancer. 2000 Jun 1;86(5):737-40. doi: 10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1. Int J Cancer. 2000. PMID: 10797299 Free article.

5

Sequence alterations can mask each other's presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples.

Orban TI, Csokay B, Olah E. Orban TI, et al. Among authors: csokay b. Biotechniques. 2000 Jul;29(1):94-8. doi: 10.2144/00291st04. Biotechniques. 2000. PMID: 10907083 Free article.

6

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.

Csokay B, Tihomirova L, Stengrevics A, Sinicka O, Olah E. Csokay B, et al. Hum Mutat. 1999;14(1):92. doi: 10.1002/(sici)1098-1004(1999)14:1<92::aid-humu23>3.0.co;2-2. Hum Mutat. 1999. PMID: 10447273

7

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

Papp J, Csokay B, Bosze P, Zalay Z, Toth J, Ponder B, Olah E. Papp J, et al. Among authors: csokay b. Br J Cancer. 1996 Nov;74(10):1592-7. doi: 10.1038/bjc.1996.594. Br J Cancer. 1996. PMID: 8932340 Free PMC article.

8

Molecular mechanisms in the antiproliferative action of quercetin.

Csokay B, Prajda N, Weber G, Olah E. Csokay B, et al. Life Sci. 1997;60(24):2157-63. doi: 10.1016/s0024-3205(97)00230-0. Life Sci. 1997. PMID: 9188758

9

[Multidrug resistance of testicular cancers. (Detection of P-glycoprotein and MDR1 gene expression and their clinical connection)].

Bak M, Hanna E, Csókay B, Bodrogi I, Oláh E. Bak M, et al. Among authors: csokay b. Orv Hetil. 1995 Jan 1;136(1):19-25. Orv Hetil. 1995. PMID: 7845662 Clinical Trial. Hungarian.

10

Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.

Olah E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA, Weber G. Olah E, et al. Among authors: csokay b. Anticancer Res. 1996 Sep-Oct;16(5A):2469-77. Anticancer Res. 1996. PMID: 8917337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page